Sumitomo Chemical India · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
While Rabi conditions appear favorable, any disruption from unseasonal rains or adverse weather could further impact H2 recovery, which is critical for annual growth targets. This risk was raised by multiple analysts.
Entire bio-stimulants industry faced sales halt from mid-June to end-September due to new regulations requiring license endorsement at manufacturing sites and state level. Varad BioSciences' 9% revenue contribution (down from 11%) remains at risk until full regulatory clearances are obtained.
Despite being discussed for years, Dahej project timelines continue to extend. Management now indicates 2028 for initial revenues, raising questions about execution capability and parent company coordination efficiency.
Brazil sales declined 33% YoY due to channel inventory liquidation and shipment delays, with no firm timeline for recovery. Analyst raised concern about international business growth expectations not materializing as planned.
